An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.
- Conditions
- Candidiasis, OralHIV Infections
- Registration Number
- NCT00002133
- Lead Sponsor
- Janssen, LP
- Brief Summary
To assess the efficacy and safety of itraconazole oral solution in HIV-seropositive patients with oropharyngeal candidiasis that is refractory to fluconazole.
- Detailed Description
Patients receive itraconazole oral solution twice daily. Per 08/15/94 amendment, patients with complete resolution of oropharyngeal candidiasis lesions upon completion of treatment are eligible for maintenance treatment on protocol FDA 236C. Patients who decline maintenance are followed for 6 weeks. Patients who relapse during follow-up are re-treated for 14-28 days; if lesions clear, patients may enter the maintenance protocol.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (18)
Univ of Alabama at Birmingham
πΊπΈBirmingham, Alabama, United States
Univ of Arkansas for Med Sciences
πΊπΈLittle Rock, Arkansas, United States
East Bay AIDS Ctr
πΊπΈBerkeley, California, United States
Kaiser Permanente Med Ctr
πΊπΈSan Francisco, California, United States
Dr Douglas Ward
πΊπΈWashington, District of Columbia, United States
George Washington Univ Med Ctr
πΊπΈWashington, District of Columbia, United States
Veterans Administration Med Ctr
πΊπΈWashington, District of Columbia, United States
Infectious Diseases Research Clinic / Indiana Univ Hosp
πΊπΈIndianapolis, Indiana, United States
Natl Inst of Allergy & Infect Dis / Cln Ctr
πΊπΈBethesda, Maryland, United States
Ann Arbor Veterans Administration Med Ctr
πΊπΈAnn Arbor, Michigan, United States
Scroll for more (8 remaining)Univ of Alabama at BirminghamπΊπΈBirmingham, Alabama, United States